by clicking the arrows at the side of the page, or by using the toolbar.
by clicking anywhere on the page.
by dragging the page around when zoomed in.
by clicking anywhere on the page when zoomed in.
web sites or send emails by clicking on hyperlinks.
Email this page to a friend
Search this issue
Index - jump to page or section
Archive - view past issues
Australian Journal of Pharmacy : November 2006
medicines than prior to communication commencement.1 Alphapharm’s medical division has played an important role in improving the acceptance of generic medicines with GPs for nearly 10 years. This relationship has resulted in Alphapharm products now being the fourth most prescribed medicines by company, or put simply, every sixth prescription written is for an Alphapharm branded medication. Alphapharm also has a dedicated pharmacy educator team to coach pharmacists and staff on how to optimise their substitution. The INFORM? it has achieved QCPP accreditation. Through the program, Alphapharm trained 7,000 pharmacy staff in 2005, and is on target to train 10,000 in 2006. The SERVICE Promise Alphapharm’s commitment to delivering high quality service has led to the company receiving industry accolades. In 2005, the company was rated number one for customer satisfaction by the Pharmacy Pulse Survey of pharmacist perceptions on their suppliers.2 But Alphapharm doesn’t rest on its laurels—it strives to improve on this service with every customer, everyday. This attitude of continuous improvement was further recognised this year when Alphapharm was the recipient of the inaugural AJP/Pharmacy Pulse Service Excellence Award—a new award offered as part of the prestigious AJP Awards. The BUSINESS Promise An important contributor to Pharmacy business success is a profi table dispensary, and so Alphapharm aims to provide pharmacies with as many profi table dispensing opportunities as possible. Alphapharm is the largest supplier (by volume) to the PBS, with 15.8 per cent of PBS scripts fi lled with an Alphapharm brand.3 Given the company offers in excess of 80 PBS lines more than its closest generic competitor, it’s not hard to see why.4 Further, the company’s PBS suite of products includes more than 100 PBS lines that are exclusive, meaning they are either the only brand or generic brand available. These include Arthrexin® Deptran® , , Dothep® , E-mycin® , Endep® , Felodur® and Lovan® ), loratidine (AllerEze® ), quinapril (Filpril® tablets.4 By the end of 2006, a further 50 lines will have been launched, including fl uconazole (Dizole® (Tacidine®), pravastatin (Cholstat® recently, zolpidem (Somidem®). ), nizatidine ), and most training program is so well regarded 2007-08 will also see Alphapharm launch a considerable number of products. “2005 marked the start of ‘The Golden Age’ of generic medicines—and with a number of big molecules coming off patent in the next few years, Alphapharm will continue to be at the forefront of profi table dispensing for Pharmacy”. said Mr Hurley. The QUALITY Promise Quality compliance is vital in pharmaceutical manufacturing, more so than in most industries. Alphapharm understands this implicitly, and employs more than 20 per cent of its staff in the company’s Quality Assurance and Quality Control departments. The company’s manufacturing facility in Carole Park meets the strict standards set out not only by the Australian TGA, but also the American FDA, the European EMEA, and the British MHRA. This ‘everyday audit-readiness’ ensures their products are always of the highest quality. The AUSTRALIAN Promise In 2005 the company’s manufacturing facility at Carole Park produced about 2.5 billion tablets and capsules. Its production capacity sees more than 70 per cent of all Alphapharm products dispensed in Australia manufactured at Carole Park. Alphapharm also employs more than 700 Australians. Further, Alphapharm’s annual investment in local research and development is on par with that of international pharmaceutical companies operating in Australia. The INTEGRITY Promise Alphapharm understands, respects and adheres to appropriate ethical standards, voluntary codes and regulations in our dealings with healthcare professionals and consumers. Being honest and up-front, honouring obligations and observing a strict duty of confi dentiality are key principles in the company’s dealings with others. Also valued is the absolute need for accurate and balanced information when assisting in prescribing, dispensing and purchasing decisions. “Alphapharm has been operating in Australia for nearly 25 years now. We have, and always will be a pharmacy-focussed organisation, and that is why we want to ensure community pharmacy knows what we stand for,” said Mr Hurley. “We look forward to our future with Pharmacy—and remain fully committed to our Promises.” REFERENCES: 1. Newspoll Generic Medicine tracking study, March 2005. 2. 2005 Pharmacy Pulse survey of Pharmacists’ Perceptions on Supplier Service Standards. 3. Pharmaceutical Benefi ts Pricing Authority – Annual Report 2005. 4. Schedule of Pharmaceutical Benefi ts, August 2006. THE AUSTRALIAN JOURNAL OF PHARMACY VOL 87 NOVEMBER 2006